Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma
Veterinary and Comparative Oncology · 2024
DOI: 10.1111/vco.12990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2024. Verfasst von Chiara Catalucci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Service, Clinica Veterinaria Malpensa AniCura, Samarate, Italy. Hauptthemen laut MEDLINE: Lomustine, Prednisolone, Dog Diseases. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Multiagent chemotherapy is considered the most effective treatment for canine high‐grade lymphoma; however, due to cost and time requirements, single‐agent protocols have also been described. The aim of our study was to evaluate the outcome and prognostic factors of dogs affected by multicentric lymphoma treated with lomustine and prednisolone as first‐line treatment. Cases of medium‐large‐cell multicentric lymphoma treated with lomustine and prednisolone were included in the study. Response to therapy, time to progression (TTP), median disease‐free interval (MDFI) and median survival time (MST) were retrospectively described. Thirty cases were included. Eleven (36.67%) were T cell, 11 (36.67%) were B cell and 8 (26.66%) had unknown immunophenotype. The overall response rate (RR) was 87%, with 15 patients achieving CR (50%) and 11 patients PR (37%). The median TTP, MDFI and MST were 42, 63 and 90 days, respectively. The only factor significantly associated with MDFI and MST was the stage. Dogs with multicentric lymphoma treated with lomustine and prednisolone have lower RR, TTP, MDFI and MST compared with dogs receiving multiagent protocols. Based on the short‐lasting response, this study confirms that this protocol might have minimal utility beyond palliation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Service, Clinica Veterinaria Malpensa AniCura, Samarate, Italy.
- Oncology Service, Clinica Veterinaria Nervianese, Nerviano, Italy.
- Oncology Service, Clinica Veterinaria Croce Blu, Alessandria, Italy.
- Oncology Service, Marigin Tierklinik, Feusisberg, Switzerland.
ORCID-Profile: Elisabetta Treggiari, Paola Valenti
Zitieren
APA
Catalucci, C., Bianchi, M. L., Treggiari, E., Pieri, M., Ruess, K., & Valenti, P. (2024). Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.12990
Vancouver
Catalucci C, Bianchi ML, Treggiari E, Pieri M, Ruess K, Valenti P. Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma. Veterinary and Comparative Oncology. 2024. doi:10.1111/vco.12990
BibTeX
@article{Catalucci2024,
author = {Catalucci, Chiara and Bianchi, Marco Luigi and Treggiari, Elisabetta and Pieri, Marta and Ruess, Katja and Valenti, Paola},
title = {Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma},
journal = {Veterinary and Comparative Oncology},
year = {2024},
doi = {10.1111/vco.12990}
}
EUVIMED